Boldenona esteroide anabolico

Equipoise is not an ideal steroid for the drug tested athlete however. This drug has the tendency to produce detectable metabolites in the urine months after use, a worry most commonly associated with Deca-Durabolin. This is of course due to the high oil solubility of long chain esterified injectable steroids, a property which enables the drug to remain deposited in fatty tissues for extended periods of time. While this will reliably slow the release of steroid into the blood stream, it also allows small residual amounts to remain present in the body far after the initial injection. The release of stubborn stores of hormone would no doubt also be enhanced around contest time, a period when the athlete drastically attempts to mobilize unwanted body fat. If enough were used in the off-season, the athlete may actually fail a drug screen for boldenone although many months may have past since the drug was last injected.


Water retention with this drug would therefore be slightly higher than that with Deca-Durabolin (with an estimated 20% conversion), but much less than we would find with a stronger compound. While there is still a chance of encountering an estrogen related side effect as such when using Equipoise, problems are usually not encountered at a moderate dosage level. 

Applications: 

Equipoise (Boldenone undecylenate) is historically a veterinary steroid but for some time has been available as an UGL human preparation as well.  For bodybuilders, it should be used as Equipoise can cause sexual dysfunction. 
In order to maintain stable blood levels, Equipoise should be injected at least once per week. It is most commonly used at a dosage of 400-600mg per week for men, 50-150 mg per week for women. 

Boldenona esteroide anabolico

boldenona esteroide anabolico

Media:

boldenona esteroide anabolicoboldenona esteroide anabolicoboldenona esteroide anabolicoboldenona esteroide anabolicoboldenona esteroide anabolico

http://buy-steroids.org